Flowhub, a Denver-based cannabis retail software company serving licensed dispensaries across the United States, has closed a $23 million funding round co-led by Evolv Ventures - the venture arm of Kraft Heinz - alongside e.ventures and Poseidon. Additional participation came from 9Yards Capital, former NBA Commissioner David Stern, and Iqram Magdon-Ismail, the co-founder and former CEO of Venmo. The deal is Evolv's first move into the cannabis sector and, for the industry, it signals something worth paying attention to: legacy consumer packaged goods money is starting to find its way into the compliance infrastructure that makes cannabis retail run.
What Flowhub Actually Does - and Why It Matters to Operators
Flowhub sits at the operational core of a licensed dispensary. Its platform covers point-of-sale processing, seed-to-sale inventory tracking, state compliance reporting, and business intelligence - the four systems that dispensary owners most urgently need to integrate, and most commonly struggle to keep synchronized. In a regulated retail environment where a single inventory discrepancy can trigger a compliance violation, and where state-mandated reporting to systems like METRC must be accurate and timely, the software a dispensary runs is not a back-office detail. It is a compliance instrument.
Cannabis retailers operate under a degree of regulatory scrutiny that most general retailers never encounter. Every product batch must carry traceability data tied to a licensed cultivator or manufacturer. Every sale must be logged against a compliant inventory record. Age verification must be enforced at the POS. Packaging requirements vary by state. And when regulations change - which they do, frequently, across the now more than 30 U.S. jurisdictions with some form of legal cannabis - operators need software that can adapt without creating gaps in their compliance logs. That is the problem Flowhub is selling a solution to, and the company reported a 200% revenue increase and a doubling of its customer base across 11 markets in the year prior to the funding announcement.
Why a Food Giant Is Backing Cannabis Retail Tech
The Kraft Heinz angle is, frankly, the most strategically interesting part of this deal. Evolv Ventures launched in October 2018 with $100 million earmarked for emerging technology companies transforming the food industry. Its prior investments include GrubMarket, a farm-to-table delivery platform, and New Culture, a startup using fermentation to produce animal-free dairy proteins. The pattern is clear: Evolv is targeting categories where consumer behavior is shifting faster than established brands can follow.
Cannabis - and CBD in particular - fits that pattern almost too neatly. The substance is among the most discussed ingredients in food and beverage innovation right now, yet U.S. regulatory clarity from the Food and Drug Administration on CBD in consumables remains unresolved. Most large CPG firms are holding their positions precisely because of that uncertainty. Backing a compliance software company rather than a CBD-infused product line is a materially different kind of bet - lower regulatory exposure, no product liability, no labeling compliance burden - while still positioning Kraft Heinz inside the industry's operational infrastructure. If FDA eventually issues rules that open the door to CBD in mainstream food and beverage, Evolv's investment in Flowhub would already have given Kraft Heinz working knowledge of how licensed cannabis retail actually functions at the store level.
The timing also reflects Kraft Heinz's own pressures. The company reported a 54.6% decline in operating income for the first half of 2019 compared to the same period in 2018, disclosed a $12.6 billion net loss in February of that year, cut its dividend by more than a third, and was subject to an SEC investigation into its procurement accounting practices. Against that backdrop, its venture arm's interest in high-growth, on-trend sectors is less surprising - and probably more urgent - than it would be for a company firing on all cylinders.
What This Round Signals for Cannabis B2B Software
The participation of Venmo co-founder Iqram Magdon-Ismail is worth a separate moment of attention. Cannabis retail has a well-documented payments problem: federal prohibition under the Controlled Substances Act means most banks and card networks have kept cannabis operators at arm's length, leaving many dispensaries dependent on cash-heavy operations that create real security risks and accounting complexity. The presence of a fintech founder in this round - alongside the core compliance and POS functionality Flowhub offers - raises a reasonable question about where the company's product roadmap may be heading.
Nielsen projected the total legalized cannabis market, including CBD, to grow from approximately $8 billion in 2018 to $41 billion by 2025. For B2B software vendors, that kind of market expansion translates into a very specific operational reality: more dispensaries opening, more SKUs flowing through POS systems, more state compliance frameworks to integrate, and more pressure on the technology layer that connects inventory to the register to the regulator. Flowhub's CEO Kyle Sherman framed his company as being on the front lines of helping cannabis brands build scalable businesses - and at the stage this industry is at, "scalable" almost always runs through compliance-ready software infrastructure.
The broader implication for cannabis operators is this: institutional capital is now moving into the tools that keep licensed retailers compliant and operational, not just into the plant-touching businesses themselves. That is a maturation signal. It also means the competitive bar for cannabis retail technology is going to rise - which, for dispensary owners evaluating their POS and compliance stack, is a reasonable moment to ask harder questions about which platforms are built to last under that kind of investor and market pressure.
